全文获取类型
收费全文 | 3471篇 |
免费 | 286篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 26篇 |
儿科学 | 87篇 |
妇产科学 | 60篇 |
基础医学 | 397篇 |
口腔科学 | 79篇 |
临床医学 | 384篇 |
内科学 | 866篇 |
皮肤病学 | 58篇 |
神经病学 | 264篇 |
特种医学 | 189篇 |
外科学 | 378篇 |
综合类 | 87篇 |
一般理论 | 2篇 |
预防医学 | 398篇 |
眼科学 | 25篇 |
药学 | 176篇 |
中国医学 | 1篇 |
肿瘤学 | 302篇 |
出版年
2021年 | 50篇 |
2020年 | 22篇 |
2019年 | 60篇 |
2018年 | 61篇 |
2017年 | 45篇 |
2016年 | 57篇 |
2015年 | 30篇 |
2014年 | 73篇 |
2013年 | 127篇 |
2012年 | 163篇 |
2011年 | 163篇 |
2010年 | 101篇 |
2009年 | 95篇 |
2008年 | 164篇 |
2007年 | 179篇 |
2006年 | 183篇 |
2005年 | 167篇 |
2004年 | 173篇 |
2003年 | 121篇 |
2002年 | 132篇 |
2001年 | 128篇 |
2000年 | 138篇 |
1999年 | 93篇 |
1998年 | 40篇 |
1997年 | 41篇 |
1996年 | 43篇 |
1995年 | 38篇 |
1994年 | 39篇 |
1993年 | 36篇 |
1992年 | 76篇 |
1991年 | 65篇 |
1990年 | 77篇 |
1989年 | 65篇 |
1988年 | 76篇 |
1987年 | 69篇 |
1986年 | 63篇 |
1985年 | 48篇 |
1984年 | 38篇 |
1983年 | 41篇 |
1982年 | 24篇 |
1981年 | 19篇 |
1979年 | 37篇 |
1978年 | 24篇 |
1977年 | 25篇 |
1976年 | 22篇 |
1975年 | 23篇 |
1973年 | 20篇 |
1972年 | 18篇 |
1971年 | 18篇 |
1969年 | 18篇 |
排序方式: 共有3779条查询结果,搜索用时 31 毫秒
991.
Cumulative scientific evidence gathered over the past ten years has confirmed the role of platelet GP IIb/IIIa inhibitors in reducing ischemic complications of patients undergoing percutaneous coronary intervention (PCI). Recently, mortality data available on more than 20,000 patients enrolled in randomized clinical trials suggest that GP IIb/IIIa blockade also improves short and long-term survival after PCI. Despite convincing arguments, GP IIb/IIIa inhibitors are still inconsistently administered in patients undergoing coronary intervention. The following review will discuss the scientific grounds and the principal controversies surrounding the use of these compounds in patients undergoing elective percutaneous coronary intervention. 相似文献
992.
J K Warner J C Y Wang K Takenaka S Doulatov J L McKenzie L Harrington J E Dick 《Leukemia》2005,19(10):1794-1805
Although genetic abnormalities associated with hematological malignancies are readily identified, the natural history of human leukemia cannot be observed because initiating and subsequent transforming events occur before clinical presentation. Furthermore, it has not been possible to study leukemogenesis in vitro as normal human cells do not spontaneously transform. Thus, the nature and sequence of genetic changes required to convert human hematopoietic cells into leukemia cells have never been directly examined. We have developed a system where the first step in the leukemogenic process is an engineered disruption of differentiation and self-renewal due to expression of the TLS-ERG oncogene, followed in some cases by overexpression of hTERT. In two of 13 experiments, transduced cells underwent step-wise transformation and immortalization through spontaneous acquisition of additional changes. The acquired karyotypic abnormalities and alterations including upregulation of Bmi-1 and telomerase all occur in acute myeloid leukemia (AML), establishing the relevance of this system. One resultant cell line studied in depth exhibits cellular properties characteristic of AML, notably a hierarchical organization initiated by leukemic stem cells that differentiate abnormally. These findings provide direct evidence for multiple cooperating events in human leukemogenesis, and provide a foundation for studying the genetic changes that occur during leukemic initiation and progression. 相似文献
993.
R. Kazi A. Singh G.P.J. Mullan R. Venkitaraman C.M. Nutting P. Clarke P. Rhys‐Evans K.J. Harrington 《Clinical otolaryngology》2006,31(6):518-524
Objectives: The primary purpose of this study was to assess the pharyngoesophageal segment in total laryngectomy patients using a videofluoroscopy e‐tool. Study design: Cross‐sectional study. Setting: Head and Neck Oncology Unit, Tertiary Referral Centre. Patients: Forty‐two patients following total laryngectomy. Intervention: Videofluoroscopy using an e‐tool (JRuler). Main outcome measures: Subjective and objective videofluoroscopy parameters correlated with the GRBAS scale and treatment variables. Results: Of 32 men and 10 women, mean age 63.5 years (10.8) the majority (64.3%) had a reasonable voice (good = 11 and poor = 4 patients). Comparing subjective and objective parameters, significant correlations were only seen with a smaller minimal neoglottic distance at phonation with no regurgitation of barium at phonation (P = 0.05) and a type 1 shape of neoglottis at phonation (P = 0.02). There were also significant correlations between smaller maximum sub‐neoglottic distance at phonation and type 1 shape of neoglottis (P = 0.02), smaller maximum sub‐neoglottic distance at rest and absence of stasis of barium at phonation (P = 0.05) and the length of neoglottis at phonation and type 1 shape of neoglottis (P = 0.01). For perceptual evaluation, significant correlation was seen only between G1 voice and a smaller minimal neoglottic distance at phonation (P = 0.03) amongst the subjective and objective parameters. There were no correlations between visual parameters and the clinical parameters. Conclusions: Our observations suggest that this interesting concept has limitations. While objective and quantifiable data can be obtained using videofluoroscopy in laryngectomees, only a few correlate with each other and with voice quality. 相似文献
994.
The CCTTT polymorphism in the NOS2A gene is associated with dementia with Lewy bodies 总被引:4,自引:0,他引:4
Xu W Liu L Emson P Harrington CR McKeith IG Perry RH Morris CM Charles IG 《Neuroreport》2000,11(2):297-299
We report the analysis of the allele distribution of a (CCTTT)n pentanucleotide repeat within the promoter region of the NOS2A gene in DNA samples from patients with autopsy confirmed Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) type. A significant difference was observed in the allelic distribution between the control group and the DLB group (chi2 = 15.175, df = 5; p<0.01), with an increased occurrence of the eight and nine repeat alleles, and a marked under representation of the 11 repeat allele. Genotype frequencies in the DLB group also differed significantly from controls (p<0.012). These results suggest that variations in the NOS2A gene may predispose to the development of DLB. 相似文献
995.
996.
997.
998.
Newby LK Califf RM White HD Harrington RA Van de Werf F Granger CB Simes RJ Hasselblad V Armstrong PW 《The American journal of medicine》2002,112(8):647-658
PURPOSE: Despite the success of intravenous glycoprotein IIb/IIIa antagonists, oral formulations have failed to show benefit and have been associated with increased mortality. To understand these findings, we performed a meta-analysis of results from four phase 3 trials. SUBJECTS AND METHODS: Trials were identified by MEDLINE search; review of abstracts from American College of Cardiology, European Society of Cardiology, and American Heart Association scientific sessions; or querying investigators in the field. Published, phase 3, randomized, placebo-controlled trials involving more than 1000 patients with coronary artery disease that compared an oral glycoprotein IIb/IIIa antagonist with or without background aspirin versus aspirin, and that had a planned follow-up of > or =30 days, were included. Four trials met these criteria. Odds ratios (ORs) and 95% confidence intervals (CIs) were generated from results, and combined using an empirical Bayes random-effects model. RESULTS: Among 33,326 patients, oral glycoprotein IIb/IIIa agents were associated with 31% increased mortality (OR = 1.31; 95% CI: 1.12 to 1.53; P= 0.0001). Results were similar whether the agent was added to (OR = 1.38; 95% CI: 1.15 to 1.67) or substituted for (OR = 1.37; 95% CI: 1.00 to 1.86) aspirin. Ischemic events or sudden death (OR = 1.22; 95% CI: 0.91 to 1.63) were also more common. Among patients with acute coronary syndromes, the incidence of myocardial infarction was increased (OR = 1.16; 95% CI: 1.03 to 1.29). CONCLUSION: Oral glycoprotein IIb/IIIa inhibitor therapy is associated with increased mortality and myocardial infarction. No single explanation for these findings is satisfactory; the problem is likely to be multifactorial. 相似文献
999.
OBJECTIVE: To test the hypothesis that operator experience influences the efficacy of light curing in a typical posterior intra-oral location. To investigate whether short cure cycles affect performance. DESIGN: A cross-sectional single-centre study designed to assess the efficacy of experienced and inexperienced operators when undertaking simulated intra-oral curing. SETTING: An in vitro laboratory based investigation conducted in a dental school during 2001. MATERIALS AND METHODS: A computer-based technique was used to monitor light intensity in a clinical simulation. Dentists and student operators were tested for their ability to cure a posterior restoration effectively. Relative light intensity was assessed against time for each operator and test run. RESULTS: Experienced (qualified) operators produced more effective and consistent cure results than less experienced undergraduate students. Operator performance was not affected by variations in irradiation time. CONCLUSIONS: This cross-sectional pilot investigation demonstrates that operator experience is a factor in successful clinical photo-curing of posterior restorations. Stable and accurate light guide positioning are required throughout the entire irradiation cycle to optimise intra-oral cure of light-activated restorations. Further investigations are planned to assess the potential of this novel method of assessment for use as a routine teaching aid in clinical practice. 相似文献
1000.
Breeman A Mercado N Lenzen M van den Brand MM Harrington RA Califf RM Topol EJ Simoons ML Boersma E;PURSUIT Investigators 《Cardiology》2002,98(4):195-201
BACKGROUND: The 6-month clinical outcome of patients with multivessel disease enrolled in PURSUIT (Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy) is described. Patients with complete angiography data were included; multivessel disease was stratified according to the treatment strategy applied early during hospitalization, i.e. medical treatment, percutaneous coronary intervention (PCI) (balloon), PCI (stent), or coronary artery bypass grafting (CABG). METHODS: Patients were divided into three groups according to the treatment strategy applied during the first 30 days of enrolment. Patients who did not undergo a percutaneous or surgical coronary intervention were classified as medically treated. Patients who underwent a PCI (prior to a possible CABG) were separated from those who underwent a CABG (prior to a possible PCI). The PCI group was further subdivided: patients receiving >/=1 coronary stents were separated from those in whom no stents were used. RESULTS: The mortality rate at 30 days was 6.7, 3.9, 2.4 and 4.8% for the medical treatment, PCI (balloon), PCI (stent) and CABG groups, respectively (p value = 0.002). Differences as observed at 30 days were still present at 6-month follow-up with 11.1, 5.8, 5.5 and 6.5% mortality event rates for the aforementioned groups (p value = 0.002). The 30-day myocardial infarction (MI) rate according to the opinion of the Clinical Events Committee was lower among medically than non-medically treated patients, with the highest event rate observed in the CABG group (27.7%). Approximately half of the MIs in the PCI and CABG subgroups occurred within 48 h after the procedure. CONCLUSIONS: The observed differences in clinical outcomes are explained by an imbalance in baseline characteristics and comorbid conditions between the analyzed groups of patients. 相似文献